Early Phase Trials
MonitorCRO pioneered the first Phase I clinical study in Turkiye in 2004 and has contributed substantially to Phase I trial setup across the country, leveraging relationships with approved investigator sites.
Key Highlights
Pioneered the first Phase I study in Turkiye (2004)
Established relationships with approved Phase I sites
First-in-human (FIH) study expertise
Pharmacokinetic and bioavailability study management
Dose-escalation study design and monitoring
Healthy volunteer recruitment capabilities